Article(id=1330233365833298718, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1330233261445460863, articleNumber=null, orderNo=null, doi=10.16522/j.cnki.cjph.2023.11.005, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=1673798400000, receivedDateStr=2023-01-16, revisedDate=null, revisedDateStr=null, acceptedDate=null, acceptedDateStr=null, onlineDate=1795081948955, onlineDateStr=2026-11-19, pubDate=1699545600000, pubDateStr=2023-11-10, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1795081948955, onlineIssueDateStr=2026-11-19, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1795081948955, creator=13701087609, updateTime=1795081948955, updator=13701087609, issue=Issue{id=1330233261445460863, tenantId=1146029695717560320, journalId=1319690259887390882, year='2023', volume='54', issue='11', pageStart='1535', pageEnd='1686', issueExtLink='null', onlineDate='null', pubDate='1699545600000', pubDateStr='2023-11-10', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=null, createTime=1795081924067, creator='13701087609', updateTime=1795082602211, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext={EN=IssueExt(id=1330236106353782847, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1330233261445460863, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1330236106353782848, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1330233261445460863, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null, downloadFileDto=null}, startPage=1569, endPage=1577, ext={EN=ArticleExt(id=1330233367460688671, articleId=1330233365833298718, tenantId=1146029695717560320, journalId=1319690259887390882, language=EN, title=General Situation of Novel Excipients for Improving Bioavailability of Cyclosporine A Ocular Preparations, columnId=1327671134809600231, journalTitle=Chinese Journal of Pharmaceuticals, columnName=Review, runingTitle=null, highlight=null, articleAbstract=

Cyclosporine A, a potent immunosuppressive agent, is extensively utilized in ophthalmic treatments. However, its high relative molecular mass and pronounced hydrophobicity pose challenges to its penetration through the physiological barriers of eyes, leading to low bioavailability. By strategically integrating innovative excipients and formulation technologies, the bioavailability of cyclosporine A can be enhanced from four aspects: increasing drug solubility, facilitating penetration through ocular mucus, boosting deep penetration into corneal tissues, and extending residence time on the ocular surface. This review focuses on the characteristics, action mechanisms, and associated formulation technologies of novel excipients employed in cyclosporine A ophthalmic formulations, to provide a reference for efficient delivery of cyclosporine A and the development of future novel formulations.

, authors=Xing DONG1, Meng YAN1, Chaoxing HE1, Suxia LI2, *, Bai XIANG1, *, authorsList=Xing DONG, Meng YAN, Chaoxing HE, Suxia LI, Bai XIANG, authorCompany=null, correspAuthors=Suxia LI, Bai XIANG, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1330233367842370336, articleId=1330233365833298718, tenantId=1146029695717560320, journalId=1319690259887390882, language=CN, title=新型辅料提高环孢素A眼部制剂生物利用度的研究概况, columnId=1327671135019315436, journalTitle=中国医药工业杂志, columnName=综述, runingTitle=null, highlight=null, articleAbstract=

环孢素A免疫抑制效力强,被广泛应用于眼科治疗中,但由于相对分子质量大、疏水性强,难以突破眼部生理屏障,导致生物利用度低。有效结合新型辅料与制剂技术,可从增加药物溶解度、促进眼表黏液穿透、增强角膜组织深层渗透以及延长眼表停留时间4个方面提高环孢素A的生物利用度。该文重点围绕环孢素A眼用制剂中应用的新型辅料的特点、作用机制和相关制剂技术进行综述,以期为实现环孢素A的高效递送和今后新型制剂的开发提供参考。

, authors=董星1, 闫梦1, 何朝星1, 李素霞2, *, 向柏1, *, authorsList=董星, 闫梦, 何朝星, 李素霞, 向柏, authorCompany=null, correspAuthors=李素霞, 向柏, authorNote=

董星(1998—),女,硕士研究生,专业方向:新型纳米药物递送系统。

, correspAuthorsNote=
李素霞(1981—),女,硕士,讲师,从事新型纳米药物递送系统的研究。E-mail:
向柏(1978—),男,博士,教授,从事新型纳米载体在疾病诊疗中的应用研究。E-mail:
, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=VR/yQTOCy7INQPWnEF5JCg==, magXml=t3KuR7QC60nmOn6Jp5nHaQ==, pdfUrl=null, pdf=5hWum8qFE4zBHd3UzSreKg==, pdfFileSize=2204145, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=aejTAqBXopPZrd4X3RK3zA==, mapNumber=null, fund=null)}, authors=[Author(id=1330233368228246312, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233365833298718, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330233368303743786, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233365833298718, authorId=1330233368228246312, language=EN, stringName=Xing DONG, firstName=Xing, middleName=null, lastName=DONG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.School of Pharmacy, Hebei Medical University, Shijiazhuang 050017, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330233368379241259, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233365833298718, authorId=1330233368228246312, language=CN, stringName=董星, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.河北医科大学药学院,河北 石家庄 050017, bio={"content":"

董星(1998—),女,硕士研究生,专业方向:新型纳米药物递送系统。

"}, bioImg=null, bioContent=

董星(1998—),女,硕士研究生,专业方向:新型纳米药物递送系统。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330233368031114017, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233365833298718, xref=1., ext=[AuthorCompanyExt(id=1330233368039502626, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233365833298718, companyId=1330233368031114017, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.School of Pharmacy, Hebei Medical University, Shijiazhuang 050017), AuthorCompanyExt(id=1330233368047891235, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233365833298718, companyId=1330233368031114017, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.河北医科大学药学院,河北 石家庄 050017)])]), Author(id=1330233368454738733, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233365833298718, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330233368559596335, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233365833298718, authorId=1330233368454738733, language=EN, stringName=Meng YAN, firstName=Meng, middleName=null, lastName=YAN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.School of Pharmacy, Hebei Medical University, Shijiazhuang 050017, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330233368635093808, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233365833298718, authorId=1330233368454738733, language=CN, stringName=闫梦, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.河北医科大学药学院,河北 石家庄 050017, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330233368031114017, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233365833298718, xref=1., ext=[AuthorCompanyExt(id=1330233368039502626, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233365833298718, companyId=1330233368031114017, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.School of Pharmacy, Hebei Medical University, Shijiazhuang 050017), AuthorCompanyExt(id=1330233368047891235, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233365833298718, companyId=1330233368031114017, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.河北医科大学药学院,河北 石家庄 050017)])]), Author(id=1330233368706396978, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233365833298718, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330233368828031796, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233365833298718, authorId=1330233368706396978, language=EN, stringName=Chaoxing HE, firstName=Chaoxing, middleName=null, lastName=HE, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.School of Pharmacy, Hebei Medical University, Shijiazhuang 050017, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330233368890946357, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233365833298718, authorId=1330233368706396978, language=CN, stringName=何朝星, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.河北医科大学药学院,河北 石家庄 050017, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330233368031114017, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233365833298718, xref=1., ext=[AuthorCompanyExt(id=1330233368039502626, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233365833298718, companyId=1330233368031114017, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.School of Pharmacy, Hebei Medical University, Shijiazhuang 050017), AuthorCompanyExt(id=1330233368047891235, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233365833298718, companyId=1330233368031114017, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.河北医科大学药学院,河北 石家庄 050017)])]), Author(id=1330233368958055223, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233365833298718, orderNo=3, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=Lisuxia1981@126.com, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1330233369037747001, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233365833298718, authorId=1330233368958055223, language=EN, stringName=Suxia LI, firstName=Suxia, middleName=null, lastName=LI, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, *, address=2.Pharmaceutical Engineering Dept., Hebei Chemical and Pharmaceutical College, Shijiazhuang 050030, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330233369100661562, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233365833298718, authorId=1330233368958055223, language=CN, stringName=李素霞, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, *, address=2.河北化工医药职业技术学院,河北 石家庄 050030, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330233368131777316, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233365833298718, xref=2., ext=[AuthorCompanyExt(id=1330233368140165925, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233365833298718, companyId=1330233368131777316, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Pharmaceutical Engineering Dept., Hebei Chemical and Pharmaceutical College, Shijiazhuang 050030), AuthorCompanyExt(id=1330233368148554534, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233365833298718, companyId=1330233368131777316, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.河北化工医药职业技术学院,河北 石家庄 050030)])]), Author(id=1330233369167770428, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233365833298718, orderNo=4, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=baixiang@hebmu.edu.cn, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1330233369247462206, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233365833298718, authorId=1330233369167770428, language=EN, stringName=Bai XIANG, firstName=Bai, middleName=null, lastName=XIANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, *, address=1.School of Pharmacy, Hebei Medical University, Shijiazhuang 050017, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330233369301988159, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233365833298718, authorId=1330233369167770428, language=CN, stringName=向柏, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, *, address=1.河北医科大学药学院,河北 石家庄 050017, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330233368031114017, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233365833298718, xref=1., ext=[AuthorCompanyExt(id=1330233368039502626, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233365833298718, companyId=1330233368031114017, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.School of Pharmacy, Hebei Medical University, Shijiazhuang 050017), AuthorCompanyExt(id=1330233368047891235, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233365833298718, companyId=1330233368031114017, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.河北医科大学药学院,河北 石家庄 050017)])])], keywords=[Keyword(id=1330233369402651456, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233365833298718, language=EN, orderNo=1, keyword=cyclosporin A), Keyword(id=1330233369473954625, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233365833298718, language=EN, orderNo=2, keyword=excipient), Keyword(id=1330233369557840707, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233365833298718, language=EN, orderNo=3, keyword=absorption-enhancing effect), Keyword(id=1330233369671086916, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233365833298718, language=EN, orderNo=4, keyword=ophthalmic preparation), Keyword(id=1330233369738195781, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233365833298718, language=EN, orderNo=5, keyword=bioavailability), Keyword(id=1330233369813693254, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233365833298718, language=CN, orderNo=1, keyword=环孢素A), Keyword(id=1330233369889190727, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233365833298718, language=CN, orderNo=2, keyword=赋形剂), Keyword(id=1330233369952105288, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233365833298718, language=CN, orderNo=3, keyword=促吸收作用), Keyword(id=1330233370098905929, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233365833298718, language=CN, orderNo=4, keyword=眼用制剂), Keyword(id=1330233370178597706, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233365833298718, language=CN, orderNo=5, keyword=生物利用度)], refs=[Reference(id=1330233372019897166, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233365833298718, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[1], rfOrder=0, authorNames=null, journalName=null, refType=null, unstructuredReference=GRIMAUDO M A, PESCINA S, PADULA C, et al. Poloxamer 407/TPGS mixed micelles as promising carriers for cyclosporine ocular delivery [J]. Mol Pharm, 2018,15(2): 571-584., articleTitle=null, refAbstract=null), Reference(id=1330233372103783247, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233365833298718, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[2], rfOrder=1, authorNames=null, journalName=null, refType=null, unstructuredReference=AL-RABIA M W, ALFALEH M A, ASFOUR H Z, et al. 2-Methoxyestradiol TPGS micelles attenuate cyclosporine A-induced nephrotoxicity in rats through inhibition of TGF-β1 and p-ERK1/2 axis [J]. A n t i o x i d a n t s (B a s e l),2 0 2 2, 1 1(8): 1 4 9 9., articleTitle=null, refAbstract=null), Reference(id=1330233372183475024, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233365833298718, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[3], rfOrder=2, authorNames=null, journalName=null, refType=null, unstructuredReference=WANG Y R, WANG C H. Novel eye drop delivery systems: advance on formulation design strategies targeting anterior and posterior segments of the eye [J]. Pharmaceutics,2022, 14(6): 1150., articleTitle=null, refAbstract=null), Reference(id=1330233372250583889, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233365833298718, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[4], rfOrder=3, authorNames=null, journalName=null, refType=null, unstructuredReference=JERKINS G W, PATTAR G R, KANNARR S R. A review of topical cyclosporine A formulations-A disease-modifying agent for keratoconjunctivitis sicca [J]. Clinical Ophthalmol, 2020, 14: 481-489., articleTitle=null, refAbstract=null), Reference(id=1330233372317692754, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233365833298718, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[5], rfOrder=4, authorNames=null, journalName=null, refType=null, unstructuredReference=JANSOOK P, OGAWA N, LOFTSSON T. Cyclodextrins:structure, physicochemical properties and pharmaceutical applications [J]. Int J Pharm, 2018, 535(1/2): 272-284., articleTitle=null, refAbstract=null), Reference(id=1330233372380607315, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233365833298718, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[6], rfOrder=5, authorNames=null, journalName=null, refType=null, unstructuredReference=STELLA V J, RAO V M, ZANNOU E A, et al. Mechanisms of drug release from cyclodextrin complexes [J]. Adv Drug Deliv Rev, 1999, 36(1): 3-16., articleTitle=null, refAbstract=null), Reference(id=1330233372468687700, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233365833298718, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[7], rfOrder=6, authorNames=null, journalName=null, refType=null, unstructuredReference=SAOKHAM P, LOFTSSON T. γ-Cyclodextrin [J]. Int J Pharm, 2017, 516(1/2): 278-292., articleTitle=null, refAbstract=null), Reference(id=1330233372552573781, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233365833298718, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[8], rfOrder=7, authorNames=null, journalName=null, refType=null, unstructuredReference=JÓHANNSDÓTTIR S, KRISTINSSON J K, FÜLÖP Z, et al. Formulations and toxicologic in vivo studies of aqueous cyclosporin A eye drops with cyclodextrin nanoparticles[J]. Int J Pharm, 2017, 529(1/2): 486-490., articleTitle=null, refAbstract=null), Reference(id=1330233372632265558, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233365833298718, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[9], rfOrder=8, authorNames=null, journalName=null, refType=null, unstructuredReference=CHAUDHARI P, BIRANGAL S, MAVLANKAR N, et al. Oil-free eye drops containing cyclosporine A/cyclodextrin/PVA supramolecular complex as a treatment modality for dry eye disease [J]. Carbohydr Polym, 2022, 297: 120007., articleTitle=null, refAbstract=null), Reference(id=1330233372716151639, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233365833298718, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[10], rfOrder=9, authorNames=null, journalName=null, refType=null, unstructuredReference=GRIMAUDO M A, NICOLI S, SANTI P, et al. Cyclosporine-loaded cross-linked inserts of sodium hyaluronan and hydroxypropyl-β-cyclodextrin for ocular administration [J]. Carbohydr Polym, 2018, 201: 308-316., articleTitle=null, refAbstract=null), Reference(id=1330233372783260504, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233365833298718, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[11], rfOrder=10, authorNames=null, journalName=null, refType=null, unstructuredReference=KASWAN R L. Intraocular penetration of topically applied cyclosporine [J]. Transplant Proc, 1988, 20(2 Suppl 2):650-655., articleTitle=null, refAbstract=null), Reference(id=1330233372862952281, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233365833298718, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[12], rfOrder=11, authorNames=null, journalName=null, refType=null, unstructuredReference=AGARWAL P, RUPENTHAL I D. Modern approaches to the ocular delivery of cyclosporine A [J]. Drug Discov Today, 2016, 21(6): 977-988., articleTitle=null, refAbstract=null), Reference(id=1330233372938449754, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233365833298718, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[13], rfOrder=12, authorNames=null, journalName=null, refType=null, unstructuredReference=CHACHAJ-BREKIESZ A, WNĘTRZAK A, LIPIEC E, et al. Perfluorohexyloctane(F6H8) as a delivery agent for cyclosporine A in dry eye syndrome therapy -Langmuir monolayer study complemented with infrared nanospectroscopy [J]. Colloids Surf B Biointerfaces, 2019,184: 110564., articleTitle=null, refAbstract=null), Reference(id=1330233373005558619, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233365833298718, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[14], rfOrder=13, authorNames=null, journalName=null, refType=null, unstructuredReference=AGARWAL P, SCHERER D, GÜNTHER B, et al. Semifluorinated alkane based systems for enhanced corneal penetration of poorly soluble drugs [J]. Int J Pharm, 2018,538(1/2): 119-129., articleTitle=null, refAbstract=null), Reference(id=1330233373076861788, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233365833298718, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[15], rfOrder=14, authorNames=null, journalName=null, refType=null, unstructuredReference=DUTESCU R M, PANFIL C, MERKEL O M, et al. Semifluorinated alkanes as a liquid drug carrier system for topical ocular drug delivery [J]. Eur J Pharm Biopharm,2014, 88(1): 123-128., articleTitle=null, refAbstract=null), Reference(id=1330233373152359261, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233365833298718, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[16], rfOrder=15, authorNames=null, journalName=null, refType=null, unstructuredReference=GEHLSEN U, BRAUN T, NOTARA M, et al. A semifluorinated alkane (F4H5) as novel carrier for cyclosporine A: a promising therapeutic and prophylactic option for topical treatment of dry eye [J]. Graefes Arch Clin Exp Ophthalmol, 2017, 255(4): 767-775., articleTitle=null, refAbstract=null), Reference(id=1330233373223662430, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233365833298718, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[17], rfOrder=16, authorNames=null, journalName=null, refType=null, unstructuredReference=WIRTA D L, TORKILDSEN G L, MOREIRA H R, et al. A clinical phase Ⅱ study to assess efficacy, safety, and tolerability of waterfree cyclosporine formulation for treatment of dry eye disease [J]. Ophthalmology, 2019,126(6): 792-800., articleTitle=null, refAbstract=null), Reference(id=1330233373320131423, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233365833298718, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[18], rfOrder=17, authorNames=null, journalName=null, refType=null, unstructuredReference=NIMBKAR S, LEENA M M, MOSES J A, et al. Medium chain triglycerides(MCT): state-of-the-art on chemistry, synthesis, health benefits and applications in food industry[J]. Compr Rev Food Sci Food Saf, 2022, 21(2): 843-867., articleTitle=null, refAbstract=null), Reference(id=1330233373408211808, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233365833298718, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[19], rfOrder=18, authorNames=null, journalName=null, refType=null, unstructuredReference=DAULL P, BAUDOUIN C, LIANG H, et al. Review of preclinical outcomes of a topical cationic emulsion of cyclosporine A for the treatment of ocular surface diseases[J]. Ocul Immunol Inflamm, 2021, 30(7/8): 1945-1955., articleTitle=null, refAbstract=null), Reference(id=1330233373466932065, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233365833298718, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[20], rfOrder=19, authorNames=null, journalName=null, refType=null, unstructuredReference=BAUDOUIN C, FIGUEIREDO F C, MESSMER E M, et al. A randomized study of the efficacy and safety of 0.1% cyclosporine A cationic emulsion in treatment of moderate to severe dry eye [J]. Eur J Ophthalmol, 2017, 27(5): 520-530., articleTitle=null, refAbstract=null), Reference(id=1330233373529846626, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233365833298718, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[21], rfOrder=20, authorNames=null, journalName=null, refType=null, unstructuredReference=BAUDOUIN C, DE LA MAZA M S, AMRANE M, et al. One-year efficacy and safety of 0.1% cyclosporine a cationic emulsion in the treatment of severe dry eye disease [J]. Eur J Ophthalmol, 2017, 27(6): 678-685., articleTitle=null, refAbstract=null), Reference(id=1330233373596955491, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233365833298718, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[22], rfOrder=21, authorNames=null, journalName=null, refType=null, unstructuredReference=LEONARDI A, DOAN S, AMRANE M, et al. A randomized, controlled trial of cyclosporine A cationic emulsion in pediatric vernal keratoconjunctivitis: the VEKTIS study [J]. Ophthalmology, 2019, 126(5): 671-681., articleTitle=null, refAbstract=null), Reference(id=1330233373697618788, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233365833298718, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[23], rfOrder=22, authorNames=null, journalName=null, refType=null, unstructuredReference=KUBIAK T. Polymeric capsules and micelles as promising carriers of anticancer drugs [J]. Polim Med, 2022, 52(1):37-50., articleTitle=null, refAbstract=null), Reference(id=1330233373764727653, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233365833298718, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[24], rfOrder=23, authorNames=null, journalName=null, refType=null, unstructuredReference=BINKHATHLAN Z, ALOMRANI A H, HOXHA O, et al. Development and characterization of PEGylated fatty acid-block-poly(epsilon-caprolactone) novel block copolymers and their self-assembled nanostructures for ocular delivery of cyclosporine A [J]. Polymers (Basel), 2022, 14(9):1635., articleTitle=null, refAbstract=null), Reference(id=1330233373827642214, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233365833298718, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[25], rfOrder=24, authorNames=null, journalName=null, refType=null, unstructuredReference=YU Y L, CHEN D Q, LI Y N, et al. Improving the topical ocular pharmacokinetics of lyophilized cyclosporine A-loaded micelles: formulation, in vitro and in vivo studies[J]. Drug Deliv, 2018, 25(1): 888-899., articleTitle=null, refAbstract=null), Reference(id=1330233373894751079, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233365833298718, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[26], rfOrder=25, authorNames=null, journalName=null, refType=null, unstructuredReference=ELDESOUKY L M, EL-MOSLEMANY R M, RAMADAN A A, et al. Cyclosporine lipid nanocapsules as thermoresponsive gel for dry eye management: promising corneal mucoadhesion, biodistribution and preclinical efficacy in rabbits [J]. Pharmaceutics, 2021, 13(3): 360., articleTitle=null, refAbstract=null), Reference(id=1330233373978637160, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233365833298718, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[27], rfOrder=26, authorNames=null, journalName=null, refType=null, unstructuredReference=HERMANS K, VAN DEN PLAS D, KERIMOVA S, et al. Development and characterization of mucoadhesive chitosan films for ophthalmic delivery of cyclosporine A [J]. Int J Pharm, 2014, 472(1/2): 10-19., articleTitle=null, refAbstract=null), Reference(id=1330233374049940329, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233365833298718, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[28], rfOrder=27, authorNames=null, journalName=null, refType=null, unstructuredReference=AKHTER S, ANWAR M, SIDDIQUI M A, et al. Improving the topical ocular pharmacokinetics of an immunosuppressant agent with mucoadhesive nanoemulsions: formulation development, in-vitro and in-vivo studies [J]. Colloids Surf B Biointerfaces, 2016, 148: 19-29., articleTitle=null, refAbstract=null), Reference(id=1330233374112854890, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233365833298718, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[29], rfOrder=28, authorNames=null, journalName=null, refType=null, unstructuredReference=GRASSIRI B, ZAMBITO Y, BERNKOP-SCHNÜRCH A. Strategies to prolong the residence time of drug delivery systems on ocular surface [J]. Adv Colloid Interface Sci,2021, 288: 102342., articleTitle=null, refAbstract=null), Reference(id=1330233374179963755, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233365833298718, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[30], rfOrder=29, authorNames=null, journalName=null, refType=null, unstructuredReference=LALLEMAND F, SCHMITT M, BOURGES J L, et al. Cyclosporine A delivery to the eye: a comprehensive review of academic and industrial efforts [J]. Eur J Pharm Biopharm, 2017, 117: 14-28., articleTitle=null, refAbstract=null), Reference(id=1330233374242878316, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233365833298718, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[31], rfOrder=30, authorNames=null, journalName=null, refType=null, unstructuredReference=TERRENI E, CHETONI P, TAMPUCCI S, et al. Assembling surfactants-mucoadhesive polymer nanomicelles(ASMP-nano) for ocular delivery of cyclosporine-A [J]. Pharmaceutics, 2020, 12(3): 253., articleTitle=null, refAbstract=null), Reference(id=1330233374318375789, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233365833298718, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[32], rfOrder=31, authorNames=null, journalName=null, refType=null, unstructuredReference=CHOLKAR K, GILGER B C, MITRA A K. Topical, aqueous, clear cyclosporine formulation design for anterior and posterior ocular delivery [J]. Transl Vis Sci Technol,2015, 4(3): 1., articleTitle=null, refAbstract=null), Reference(id=1330233374410650478, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233365833298718, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[33], rfOrder=32, authorNames=null, journalName=null, refType=null, unstructuredReference=PENG W Y, CHEN R X, DAI H, et al. Efficacy, safety, and tolerability of a novel cyclosporine, a formulation for dry eye disease: a multicenter phase Ⅱ clinical study [J]. Clin Ther, 2021, 43(3): 613-628., articleTitle=null, refAbstract=null), Reference(id=1330233374477759343, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233365833298718, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[34], rfOrder=33, authorNames=null, journalName=null, refType=null, unstructuredReference=DUAN Y W, CAI X Q, DU H L, et al. Novel in situ gel systems based on P123/TPGS mixed micelles and gellan gum for ophthalmic delivery of curcumin [J]. Colloids Surf B Biointerfaces, 2015, 128: 322-330., articleTitle=null, refAbstract=null), Reference(id=1330233374591005552, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233365833298718, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[35], rfOrder=34, authorNames=null, journalName=null, refType=null, unstructuredReference=WU Y J, YAO J, ZHOU J P, et al. Enhanced and sustained topical ocular delivery of cyclosporine A in thermosensitive hyaluronic acid-based in situ forming microgels [J]. Int J Nanomedicine, 2013, 8: 3587-3601., articleTitle=null, refAbstract=null), Reference(id=1330233374658114417, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233365833298718, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[36], rfOrder=35, authorNames=null, journalName=null, refType=null, unstructuredReference=TERRENI E, ZUCCHETTI E, TAMPUCCI S, et al. Combination of nanomicellar technology and in situ gelling polymer as ocular drug delivery system(ODDS) for cyclosporine-A [J]. Pharmaceutics, 2021, 13(2): 192., articleTitle=null, refAbstract=null), Reference(id=1330233376289698674, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233365833298718, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[37], rfOrder=36, authorNames=null, journalName=null, refType=null, unstructuredReference=ASHARA K C, PAUN J S, SONIWALA M M, et al. Microemulgel: an overwhelming approach to improve therapeutic action of drug moiety [J]. Saudi Pharm J, 2016,24(4): 452-457., articleTitle=null, refAbstract=null), Reference(id=1330233376402944883, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233365833298718, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[38], rfOrder=37, authorNames=null, journalName=null, refType=null, unstructuredReference=SHEN Y, LING X, JIANG W W, et al. Formulation and evaluation of cyclosporin A emulgel for ocular delivery[J]. Drug Deliv, 2015, 22(7): 911-917., articleTitle=null, refAbstract=null), Reference(id=1330233376478442356, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233365833298718, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[39], rfOrder=38, authorNames=null, journalName=null, refType=null, unstructuredReference=HASANNIA M, ALIABADI A, ABNOUS K, et al. Synthesis of block copolymers used in polymersome fabrication: application in drug delivery [J]. J Control Release, 2022, 341: 95-117., articleTitle=null, refAbstract=null), Reference(id=1330233376545551221, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233365833298718, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[40], rfOrder=39, authorNames=null, journalName=null, refType=null, unstructuredReference=ALSHAMSAN A, ABUL KALAM M, VAKILI M R, et al. Treatment of endotoxin-induced uveitis by topical application of cyclosporine a-loaded PolyGel™ in rabbit eyes [J]. Int J Pharm, 2019, 569: 118573., articleTitle=null, refAbstract=null), Reference(id=1330233376629437302, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233365833298718, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[41], rfOrder=40, authorNames=null, journalName=null, refType=null, unstructuredReference=PROSPERI-PORTA G, KEDZIOR S, MUIRHEAD B, et al. Phenylboronic-acid-based polymeric micelles for mucoadhesive anterior segment ocular drug delivery [J]. Biomacromolecules, 2016, 17(4): 1449-1457., articleTitle=null, refAbstract=null), Reference(id=1330233376713323383, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233365833298718, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[42], rfOrder=41, authorNames=null, journalName=null, refType=null, unstructuredReference=HUCKABY J T, LAI S K. PEGylation for enhancing nanoparticle diffusion in mucus [J]. Adv Drug Deliv Rev,2018, 124: 125-139., articleTitle=null, refAbstract=null), Reference(id=1330233376767849336, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233365833298718, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[43], rfOrder=42, authorNames=null, journalName=null, refType=null, unstructuredReference=POPOV A. Mucus-penetrating particles and the role of ocular mucus as a barrier to micro- and nanosuspensions[J]. J Ocul Pharmacol Ther, 2020, 36(6): 366-375., articleTitle=null, refAbstract=null), Reference(id=1330233376830763897, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233365833298718, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[44], rfOrder=43, authorNames=null, journalName=null, refType=null, unstructuredReference=YAN R, XU L, WANG Q H, et al. Cyclosporine A nanosuspensions for ophthalmic delivery: a comparative study between cationic nanoparticles and drug-core mucus penetrating nanoparticles [J]. Mol Pharm, 2021, 18(12):4290-4298., articleTitle=null, refAbstract=null), Reference(id=1330233376906261370, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233365833298718, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[45], rfOrder=44, authorNames=null, journalName=null, refType=null, unstructuredReference=DAULL P, LALLEMAND F, GARRIGUE J S. Benefits of cetalkonium chloride cationic oil-in-water nanoemulsions for topical ophthalmic drug delivery [J]. J Pharm Pharmacol, 2014, 66(4): 531-541., articleTitle=null, refAbstract=null), Reference(id=1330233376985953147, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233365833298718, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[46], rfOrder=45, authorNames=null, journalName=null, refType=null, unstructuredReference=DAULL P, FERAILLE L, BARABINO S, et al. Efficacy of a new topical cationic emulsion of cyclosporine A on dry eye clinical signs in an experimental mouse model of dry eye[J]. Exp Eye Res, 2016, 153: 159-164., articleTitle=null, refAbstract=null), Reference(id=1330233377078227836, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233365833298718, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[47], rfOrder=46, authorNames=null, journalName=null, refType=null, unstructuredReference=LANGEL Ü. Cell-penetrating peptides and transportan[J]. Pharmaceutics, 2021, 13(7): 987., articleTitle=null, refAbstract=null), Reference(id=1330233377145336701, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233365833298718, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[48], rfOrder=47, authorNames=null, journalName=null, refType=null, unstructuredReference=PESCINA S, OSTACOLO C, GOMEZ-MONTERREY I M, et al. Cell penetrating peptides in ocular drug delivery: state of the art [J]. J Control Release, 2018, 284: 84-102., articleTitle=null, refAbstract=null), Reference(id=1330233377212445566, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233365833298718, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[49], rfOrder=48, authorNames=null, journalName=null, refType=null, unstructuredReference=HYUN S, LI L, YOON K C, et al. An amphipathic cell penetrating peptide aids cell penetration of cyclosporin A and increases its therapeutic effect in an in vivo mouse model for dry eye disease [J]. Chem Commun (Camb), 2019,55(91): 13657-13660., articleTitle=null, refAbstract=null), Reference(id=1330233377283748735, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233365833298718, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[50], rfOrder=49, authorNames=null, journalName=null, refType=null, unstructuredReference=ZAMBOULIS A, NANAKI S, MICHAILIDOU G, et al. Chitosan and its derivatives for ocular delivery formulations:recent advances and developments [J]. Polymers (Basel),2020, 12(7): 1519., articleTitle=null, refAbstract=null), Reference(id=1330233377359246208, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233365833298718, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[51], rfOrder=50, authorNames=null, journalName=null, refType=null, unstructuredReference=BONFERONI M C, SANDRI G, DELLERA E, et al. Palmitoyl glycol chitosan micelles for corneal delivery of cyclosporine [J]. J Biomed Nanotechnol, 2016, 12(1): 231-240., articleTitle=null, refAbstract=null), Reference(id=1330233377426355073, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233365833298718, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[52], rfOrder=51, authorNames=null, journalName=null, refType=null, unstructuredReference=UCHEGBU I F, BREZNIKAR J, ZAFFALON A, et al. Polymeric micelles for the enhanced deposition of hydrophobic drugs into ocular tissues, without plasma exposure [J]. Pharmaceutics, 2021, 13(5): 744., articleTitle=null, refAbstract=null), Reference(id=1330233377485075330, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233365833298718, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[53], rfOrder=52, authorNames=null, journalName=null, refType=null, unstructuredReference=ALVAREZ-TRABADO J, LÓPEZ-GARCÍA A, MARTíN-PASTOR M, et al. Sorbitan ester nanoparticles(SENS) as a novel topical ocular drug delivery system: design, optimization, and in vitro/ex vivo evaluation [J]. Int J Pharm, 2018, 546(1/2): 20-30., articleTitle=null, refAbstract=null), Reference(id=1330233377568961411, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233365833298718, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[54], rfOrder=53, authorNames=null, journalName=null, refType=null, unstructuredReference=LIU Y, WANG Y N, YANG J L, et al. Cationized hyaluronic acid coated spanlastics for cyclosporine A ocular delivery:prolonged ocular retention, enhanced corneal permeation and improved tear production [J]. Int J Pharm, 2019, 565: 133-142., articleTitle=null, refAbstract=null), Reference(id=1330233377644458884, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233365833298718, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[55], rfOrder=54, authorNames=null, journalName=null, refType=null, unstructuredReference=MUN J, MOK J W, JEONG S, et al. Drug-eluting contact lens containing cyclosporine-loaded cholesterol-hyaluronate micelles for dry eye syndrome [J]. RSC Adv, 2019, 9(29):16578-16585., articleTitle=null, refAbstract=null), Reference(id=1330233377711567749, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233365833298718, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[56], rfOrder=55, authorNames=null, journalName=null, refType=null, unstructuredReference=UWAEZUOKE O, DU TOIT L C, KUMAR P, et al. Linoleic acid-based transferosomes for topical ocular delivery of cyclosporine A [J]. Pharmaceutics, 2022, 14(8): 1695., articleTitle=null, refAbstract=null), Reference(id=1330233377770288006, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233365833298718, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[57], rfOrder=56, authorNames=null, journalName=null, refType=null, unstructuredReference=GHEZZI M, FERRABOSCHI I, DELLEDONNE A, et al. Cyclosporine-loaded micelles for ocular delivery:investigating the penetration mechanisms [J]. J Control Release, 2022, 349: 744-755., articleTitle=null, refAbstract=null)], funds=[Fund(id=1330233371818570571, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233365833298718, awardId=81973251, language=CN, fundingSource=国家自然科学基金资助项目(81973251), fundOrder=null, country=null), Fund(id=1330233371873096524, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233365833298718, awardId=H2019206445, language=CN, fundingSource=河北省自然科学基金资助项目(H2019206445), fundOrder=null, country=null), Fund(id=1330233371936011085, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233365833298718, awardId=20211108, language=CN, fundingSource=河北省2021年度医学科学研究课题(20211108), fundOrder=null, country=null)], companyList=[AuthorCompany(id=1330233368031114017, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233365833298718, xref=1., ext=[AuthorCompanyExt(id=1330233368039502626, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233365833298718, companyId=1330233368031114017, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.School of Pharmacy, Hebei Medical University, Shijiazhuang 050017), AuthorCompanyExt(id=1330233368047891235, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233365833298718, companyId=1330233368031114017, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.河北医科大学药学院,河北 石家庄 050017)]), AuthorCompany(id=1330233368131777316, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233365833298718, xref=2., ext=[AuthorCompanyExt(id=1330233368140165925, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233365833298718, companyId=1330233368131777316, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Pharmaceutical Engineering Dept., Hebei Chemical and Pharmaceutical College, Shijiazhuang 050030), AuthorCompanyExt(id=1330233368148554534, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233365833298718, companyId=1330233368131777316, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.河北化工医药职业技术学院,河北 石家庄 050030)])], figs=null, attaches=null, journal=Journal(id=1319689822849302687, delFlag=0, nameCn=中国医药工业杂志, nameEn=Chinese Journal of Pharmaceuticals, nameHistory1=null, nameHistory2=null, issn=1001-8255, eissn=null, cn=31-1243/R, coden=ZYGZEA, periodic=0, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=etiWDuwx2KO274LHw88KJA==, journalPrice=null, startedYear=null, abbrevIsoEn=Chinese Journal of Pharmaceuticals, journalRemark=null, publicationField=null, createdTime=1792568172420, updatedTime=1792747450744, createdBy=18614031015, updatedBy=13701087609, firstLetterCn=Z, firstLetterEn=Z, subjectCode=Medical and Pharmaceutical Sciences, subjectName=null, subjectCodeEn=Medical and Pharmaceutical Sciences, subjectNameEn=null, picCn=etiWDuwx2KO274LHw88KJA==, picEn=ip9NF4dK57AmNrCiZ6hmdw==, jcr=null, cjcr=null, exts=[JournalExt(id=1320441770761105589, language=CN, name=中国医药工业杂志, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747450771, updatedTime=1792747450771, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=https://zgyygyauthor.cast.org.cn/webm, submissionEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionReviewUrl=https://zgyygyauthor.cast.org.cn/webm, submissionCeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionAeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, option={"copyright":""}), JournalExt(id=1320441770819825846, language=EN, name=Chinese Journal of Pharmaceuticals, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747450785, updatedTime=1792747450785, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=https://zgyygyauthor.cast.org.cn/webm, submissionEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionReviewUrl=https://zgyygyauthor.cast.org.cn/webm, submissionCeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionAeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, option={"copyright":""})], databaseList=null, tenantJournalId=1319690259887390882, websiteList=[Website(id=1319720771623174732, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690259887390882, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgyygy/CN, language=CN, createTime=1792575551181, createBy=18614031015, updateTime=1792746040843, updateBy=18614031015, name=中国医药工业杂志-中文, tplId=1146099689490845704, title=中国医药工业杂志, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428487504769041, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=articleTextType, value=kx, createTime=1792982702375, updateTime=1792982702375, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487475408910, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=banner, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic?fileId=i/3+mr8MqWvs6ArWn9VK7w==, createTime=1792982702368, updateTime=1792982702368, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487538323476, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=grayFlag, value=0, createTime=1792982702383, updateTime=1792982702383, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487462825997, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=logo, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic?fileId=7mfvc3zMp/tsQUIOlJrNFQ==, createTime=1792982702365, updateTime=1792982702365, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487571877910, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=minRunFlag, value=0, createTime=1792982702391, updateTime=1792982702391, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487496380432, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic, createTime=1792982702373, updateTime=1792982702373, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487563489301, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=silenceFlag, value=0, createTime=1792982702389, updateTime=1792982702389, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487483797519, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1792982702370, updateTime=1792982702370, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487517351954, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=themeColor, value=null, createTime=1792982702378, updateTime=1792982702378, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487525740563, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982702380, updateTime=1792982702380, creator=18614031015, updator=18614031015)]), Website(id=1319720771702866512, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690259887390882, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgyygy/EN, language=EN, createTime=1792575551200, createBy=18614031015, updateTime=1792746037543, updateBy=18614031015, name=中国医药工业杂志-英文, tplId=1146101810881728533, title=Chinese Journal of Pharmaceuticals, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428509638111261, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=articleTextType, value=kx, createTime=1792982707652, updateTime=1792982707652, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509579391002, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=banner, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic?fileId=i/3+mr8MqWvs6ArWn9VK7w==, createTime=1792982707638, updateTime=1792982707638, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509680054304, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=grayFlag, value=0, createTime=1792982707662, updateTime=1792982707662, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509566808089, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=logo, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic?fileId=7mfvc3zMp/tsQUIOlJrNFQ==, createTime=1792982707635, updateTime=1792982707635, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509701025826, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=minRunFlag, value=0, createTime=1792982707667, updateTime=1792982707667, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509629722652, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic, createTime=1792982707650, updateTime=1792982707650, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509688442913, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=silenceFlag, value=0, createTime=1792982707664, updateTime=1792982707664, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509587779611, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1792982707640, updateTime=1792982707640, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509663277086, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=themeColor, value=null, createTime=1792982707658, updateTime=1792982707658, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509671665695, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982707660, updateTime=1792982707660, creator=18614031015, updator=18614031015)])], journalTitle=中国医药工业杂志, weixinUrl=null, journalUrl=http://www.cjph.com.cn/, iacademicId=null, status=1, seqNo=null, journalTitleEn=Chinese Journal of Pharmaceuticals, journalPhotoCn=etiWDuwx2KO274LHw88KJA==, journalPhotoEn=ip9NF4dK57AmNrCiZ6hmdw==, journalFirstLetter=Z, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false, interPubPlatform=, interPubPlatformUrl=null), detailUrlCn=https://castjournals.cast.org.cn/joweb/zgyygy/CN/10.16522/j.cnki.cjph.2023.11.005, detailUrlEn=https://castjournals.cast.org.cn/joweb/zgyygy/EN/10.16522/j.cnki.cjph.2023.11.005, pdfUrlCn=https://castjournals.cast.org.cn/joweb/zgyygy/CN/PDF/10.16522/j.cnki.cjph.2023.11.005, pdfUrlEn=https://castjournals.cast.org.cn/joweb/zgyygy/EN/PDF/10.16522/j.cnki.cjph.2023.11.005, aliStartDate=0, aliEndDate=0, collectionFlag=false, citedCount=null, citedUrl=null, previewStatus=0, delFlag=0, hasFullText=0, orderTime=1699545600000, fullTextJson=null, articleText=null, reference=null)
收藏切换
新型辅料提高环孢素A眼部制剂生物利用度的研究概况
董星 1 , 闫梦 1 , 何朝星 1 , 李素霞 2, * , 向柏 1, *
中国医药工业杂志 | 综述 2023,54(11): 1569-1577
收起
收藏切换
中国医药工业杂志 |综述 2023 , 54 (11) : 1569 -1577
新型辅料提高环孢素A眼部制剂生物利用度的研究概况
全屏
[Author(id=1330233368228246312, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233365833298718, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330233368303743786, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233365833298718, authorId=1330233368228246312, language=EN, stringName=Xing DONG, firstName=Xing, middleName=null, lastName=DONG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.School of Pharmacy, Hebei Medical University, Shijiazhuang 050017, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330233368379241259, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233365833298718, authorId=1330233368228246312, language=CN, stringName=董星, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.河北医科大学药学院,河北 石家庄 050017, bio={"content":"

董星(1998—),女,硕士研究生,专业方向:新型纳米药物递送系统。

"}, bioImg=null, bioContent=

董星(1998—),女,硕士研究生,专业方向:新型纳米药物递送系统。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330233368031114017, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233365833298718, xref=1., ext=[AuthorCompanyExt(id=1330233368039502626, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233365833298718, companyId=1330233368031114017, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.School of Pharmacy, Hebei Medical University, Shijiazhuang 050017), AuthorCompanyExt(id=1330233368047891235, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233365833298718, companyId=1330233368031114017, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.河北医科大学药学院,河北 石家庄 050017)])]), Author(id=1330233368454738733, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233365833298718, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330233368559596335, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233365833298718, authorId=1330233368454738733, language=EN, stringName=Meng YAN, firstName=Meng, middleName=null, lastName=YAN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.School of Pharmacy, Hebei Medical University, Shijiazhuang 050017, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330233368635093808, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233365833298718, authorId=1330233368454738733, language=CN, stringName=闫梦, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.河北医科大学药学院,河北 石家庄 050017, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330233368031114017, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233365833298718, xref=1., ext=[AuthorCompanyExt(id=1330233368039502626, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233365833298718, companyId=1330233368031114017, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.School of Pharmacy, Hebei Medical University, Shijiazhuang 050017), AuthorCompanyExt(id=1330233368047891235, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233365833298718, companyId=1330233368031114017, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.河北医科大学药学院,河北 石家庄 050017)])]), Author(id=1330233368706396978, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233365833298718, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330233368828031796, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233365833298718, authorId=1330233368706396978, language=EN, stringName=Chaoxing HE, firstName=Chaoxing, middleName=null, lastName=HE, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.School of Pharmacy, Hebei Medical University, Shijiazhuang 050017, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330233368890946357, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233365833298718, authorId=1330233368706396978, language=CN, stringName=何朝星, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.河北医科大学药学院,河北 石家庄 050017, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330233368031114017, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233365833298718, xref=1., ext=[AuthorCompanyExt(id=1330233368039502626, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233365833298718, companyId=1330233368031114017, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.School of Pharmacy, Hebei Medical University, Shijiazhuang 050017), AuthorCompanyExt(id=1330233368047891235, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233365833298718, companyId=1330233368031114017, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.河北医科大学药学院,河北 石家庄 050017)])]), Author(id=1330233368958055223, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233365833298718, orderNo=3, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=Lisuxia1981@126.com, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1330233369037747001, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233365833298718, authorId=1330233368958055223, language=EN, stringName=Suxia LI, firstName=Suxia, middleName=null, lastName=LI, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, *, address=2.Pharmaceutical Engineering Dept., Hebei Chemical and Pharmaceutical College, Shijiazhuang 050030, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330233369100661562, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233365833298718, authorId=1330233368958055223, language=CN, stringName=李素霞, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, *, address=2.河北化工医药职业技术学院,河北 石家庄 050030, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330233368131777316, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233365833298718, xref=2., ext=[AuthorCompanyExt(id=1330233368140165925, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233365833298718, companyId=1330233368131777316, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Pharmaceutical Engineering Dept., Hebei Chemical and Pharmaceutical College, Shijiazhuang 050030), AuthorCompanyExt(id=1330233368148554534, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233365833298718, companyId=1330233368131777316, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.河北化工医药职业技术学院,河北 石家庄 050030)])]), Author(id=1330233369167770428, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233365833298718, orderNo=4, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=baixiang@hebmu.edu.cn, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1330233369247462206, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233365833298718, authorId=1330233369167770428, language=EN, stringName=Bai XIANG, firstName=Bai, middleName=null, lastName=XIANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, *, address=1.School of Pharmacy, Hebei Medical University, Shijiazhuang 050017, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330233369301988159, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233365833298718, authorId=1330233369167770428, language=CN, stringName=向柏, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, *, address=1.河北医科大学药学院,河北 石家庄 050017, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330233368031114017, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233365833298718, xref=1., ext=[AuthorCompanyExt(id=1330233368039502626, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233365833298718, companyId=1330233368031114017, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.School of Pharmacy, Hebei Medical University, Shijiazhuang 050017), AuthorCompanyExt(id=1330233368047891235, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233365833298718, companyId=1330233368031114017, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.河北医科大学药学院,河北 石家庄 050017)])])]
董星1, 闫梦1, 何朝星1, 李素霞2, * , 向柏1, *
作者信息
  • 1.河北医科大学药学院,河北 石家庄 050017
  • 2.河北化工医药职业技术学院,河北 石家庄 050030
通讯作者:
李素霞(1981—),女,硕士,讲师,从事新型纳米药物递送系统的研究。E-mail:
向柏(1978—),男,博士,教授,从事新型纳米载体在疾病诊疗中的应用研究。E-mail:
作者简介:

董星(1998—),女,硕士研究生,专业方向:新型纳米药物递送系统。

General Situation of Novel Excipients for Improving Bioavailability of Cyclosporine A Ocular Preparations
Xing DONG1, Meng YAN1, Chaoxing HE1, Suxia LI2, * , Bai XIANG1, *
Affiliations
  • 1.School of Pharmacy, Hebei Medical University, Shijiazhuang 050017
  • 2.Pharmaceutical Engineering Dept., Hebei Chemical and Pharmaceutical College, Shijiazhuang 050030
出版时间: 2023-11-10 doi: 10.16522/j.cnki.cjph.2023.11.005
文章导航
收藏切换

环孢素A免疫抑制效力强,被广泛应用于眼科治疗中,但由于相对分子质量大、疏水性强,难以突破眼部生理屏障,导致生物利用度低。有效结合新型辅料与制剂技术,可从增加药物溶解度、促进眼表黏液穿透、增强角膜组织深层渗透以及延长眼表停留时间4个方面提高环孢素A的生物利用度。该文重点围绕环孢素A眼用制剂中应用的新型辅料的特点、作用机制和相关制剂技术进行综述,以期为实现环孢素A的高效递送和今后新型制剂的开发提供参考。

环孢素A  /  赋形剂  /  促吸收作用  /  眼用制剂  /  生物利用度

Cyclosporine A, a potent immunosuppressive agent, is extensively utilized in ophthalmic treatments. However, its high relative molecular mass and pronounced hydrophobicity pose challenges to its penetration through the physiological barriers of eyes, leading to low bioavailability. By strategically integrating innovative excipients and formulation technologies, the bioavailability of cyclosporine A can be enhanced from four aspects: increasing drug solubility, facilitating penetration through ocular mucus, boosting deep penetration into corneal tissues, and extending residence time on the ocular surface. This review focuses on the characteristics, action mechanisms, and associated formulation technologies of novel excipients employed in cyclosporine A ophthalmic formulations, to provide a reference for efficient delivery of cyclosporine A and the development of future novel formulations.

cyclosporin A  /  excipient  /  absorption-enhancing effect  /  ophthalmic preparation  /  bioavailability
董星, 闫梦, 何朝星, 李素霞, 向柏. 新型辅料提高环孢素A眼部制剂生物利用度的研究概况. 中国医药工业杂志, 2023 , 54 (11) : 1569 -1577 . DOI: 10.16522/j.cnki.cjph.2023.11.005
Xing DONG, Meng YAN, Chaoxing HE, Suxia LI, Bai XIANG. General Situation of Novel Excipients for Improving Bioavailability of Cyclosporine A Ocular Preparations[J]. Chinese Journal of Pharmaceuticals, 2023 , 54 (11) : 1569 -1577 . DOI: 10.16522/j.cnki.cjph.2023.11.005
  • 国家自然科学基金资助项目(81973251)
  • 河北省自然科学基金资助项目(H2019206445)
  • 河北省2021年度医学科学研究课题(20211108)
参考文献 引证文献
排序方式:
[1]
GRIMAUDO M A, PESCINA S, PADULA C, et al. Poloxamer 407/TPGS mixed micelles as promising carriers for cyclosporine ocular delivery [J]. Mol Pharm, 2018,15(2): 571-584.
[2]
AL-RABIA M W, ALFALEH M A, ASFOUR H Z, et al. 2-Methoxyestradiol TPGS micelles attenuate cyclosporine A-induced nephrotoxicity in rats through inhibition of TGF-β1 and p-ERK1/2 axis [J]. A n t i o x i d a n t s (B a s e l),2 0 2 2, 1 1(8): 1 4 9 9.
[3]
WANG Y R, WANG C H. Novel eye drop delivery systems: advance on formulation design strategies targeting anterior and posterior segments of the eye [J]. Pharmaceutics,2022, 14(6): 1150.
[4]
JERKINS G W, PATTAR G R, KANNARR S R. A review of topical cyclosporine A formulations-A disease-modifying agent for keratoconjunctivitis sicca [J]. Clinical Ophthalmol, 2020, 14: 481-489.
[5]
JANSOOK P, OGAWA N, LOFTSSON T. Cyclodextrins:structure, physicochemical properties and pharmaceutical applications [J]. Int J Pharm, 2018, 535(1/2): 272-284.
[6]
STELLA V J, RAO V M, ZANNOU E A, et al. Mechanisms of drug release from cyclodextrin complexes [J]. Adv Drug Deliv Rev, 1999, 36(1): 3-16.
[7]
SAOKHAM P, LOFTSSON T. γ-Cyclodextrin [J]. Int J Pharm, 2017, 516(1/2): 278-292.
[8]
JÓHANNSDÓTTIR S, KRISTINSSON J K, FÜLÖP Z, et al. Formulations and toxicologic in vivo studies of aqueous cyclosporin A eye drops with cyclodextrin nanoparticles[J]. Int J Pharm, 2017, 529(1/2): 486-490.
[9]
CHAUDHARI P, BIRANGAL S, MAVLANKAR N, et al. Oil-free eye drops containing cyclosporine A/cyclodextrin/PVA supramolecular complex as a treatment modality for dry eye disease [J]. Carbohydr Polym, 2022, 297: 120007.
[10]
GRIMAUDO M A, NICOLI S, SANTI P, et al. Cyclosporine-loaded cross-linked inserts of sodium hyaluronan and hydroxypropyl-β-cyclodextrin for ocular administration [J]. Carbohydr Polym, 2018, 201: 308-316.
[11]
KASWAN R L. Intraocular penetration of topically applied cyclosporine [J]. Transplant Proc, 1988, 20(2 Suppl 2):650-655.
[12]
AGARWAL P, RUPENTHAL I D. Modern approaches to the ocular delivery of cyclosporine A [J]. Drug Discov Today, 2016, 21(6): 977-988.
[13]
CHACHAJ-BREKIESZ A, WNĘTRZAK A, LIPIEC E, et al. Perfluorohexyloctane(F6H8) as a delivery agent for cyclosporine A in dry eye syndrome therapy -Langmuir monolayer study complemented with infrared nanospectroscopy [J]. Colloids Surf B Biointerfaces, 2019,184: 110564.
[14]
AGARWAL P, SCHERER D, GÜNTHER B, et al. Semifluorinated alkane based systems for enhanced corneal penetration of poorly soluble drugs [J]. Int J Pharm, 2018,538(1/2): 119-129.
[15]
DUTESCU R M, PANFIL C, MERKEL O M, et al. Semifluorinated alkanes as a liquid drug carrier system for topical ocular drug delivery [J]. Eur J Pharm Biopharm,2014, 88(1): 123-128.
[16]
GEHLSEN U, BRAUN T, NOTARA M, et al. A semifluorinated alkane (F4H5) as novel carrier for cyclosporine A: a promising therapeutic and prophylactic option for topical treatment of dry eye [J]. Graefes Arch Clin Exp Ophthalmol, 2017, 255(4): 767-775.
[17]
WIRTA D L, TORKILDSEN G L, MOREIRA H R, et al. A clinical phase Ⅱ study to assess efficacy, safety, and tolerability of waterfree cyclosporine formulation for treatment of dry eye disease [J]. Ophthalmology, 2019,126(6): 792-800.
[18]
NIMBKAR S, LEENA M M, MOSES J A, et al. Medium chain triglycerides(MCT): state-of-the-art on chemistry, synthesis, health benefits and applications in food industry[J]. Compr Rev Food Sci Food Saf, 2022, 21(2): 843-867.
[19]
DAULL P, BAUDOUIN C, LIANG H, et al. Review of preclinical outcomes of a topical cationic emulsion of cyclosporine A for the treatment of ocular surface diseases[J]. Ocul Immunol Inflamm, 2021, 30(7/8): 1945-1955.
[20]
BAUDOUIN C, FIGUEIREDO F C, MESSMER E M, et al. A randomized study of the efficacy and safety of 0.1% cyclosporine A cationic emulsion in treatment of moderate to severe dry eye [J]. Eur J Ophthalmol, 2017, 27(5): 520-530.
[21]
BAUDOUIN C, DE LA MAZA M S, AMRANE M, et al. One-year efficacy and safety of 0.1% cyclosporine a cationic emulsion in the treatment of severe dry eye disease [J]. Eur J Ophthalmol, 2017, 27(6): 678-685.
[22]
LEONARDI A, DOAN S, AMRANE M, et al. A randomized, controlled trial of cyclosporine A cationic emulsion in pediatric vernal keratoconjunctivitis: the VEKTIS study [J]. Ophthalmology, 2019, 126(5): 671-681.
[23]
KUBIAK T. Polymeric capsules and micelles as promising carriers of anticancer drugs [J]. Polim Med, 2022, 52(1):37-50.
[24]
BINKHATHLAN Z, ALOMRANI A H, HOXHA O, et al. Development and characterization of PEGylated fatty acid-block-poly(epsilon-caprolactone) novel block copolymers and their self-assembled nanostructures for ocular delivery of cyclosporine A [J]. Polymers (Basel), 2022, 14(9):1635.
[25]
YU Y L, CHEN D Q, LI Y N, et al. Improving the topical ocular pharmacokinetics of lyophilized cyclosporine A-loaded micelles: formulation, in vitro and in vivo studies[J]. Drug Deliv, 2018, 25(1): 888-899.
[26]
ELDESOUKY L M, EL-MOSLEMANY R M, RAMADAN A A, et al. Cyclosporine lipid nanocapsules as thermoresponsive gel for dry eye management: promising corneal mucoadhesion, biodistribution and preclinical efficacy in rabbits [J]. Pharmaceutics, 2021, 13(3): 360.
[27]
HERMANS K, VAN DEN PLAS D, KERIMOVA S, et al. Development and characterization of mucoadhesive chitosan films for ophthalmic delivery of cyclosporine A [J]. Int J Pharm, 2014, 472(1/2): 10-19.
[28]
AKHTER S, ANWAR M, SIDDIQUI M A, et al. Improving the topical ocular pharmacokinetics of an immunosuppressant agent with mucoadhesive nanoemulsions: formulation development, in-vitro and in-vivo studies [J]. Colloids Surf B Biointerfaces, 2016, 148: 19-29.
[29]
GRASSIRI B, ZAMBITO Y, BERNKOP-SCHNÜRCH A. Strategies to prolong the residence time of drug delivery systems on ocular surface [J]. Adv Colloid Interface Sci,2021, 288: 102342.
[30]
LALLEMAND F, SCHMITT M, BOURGES J L, et al. Cyclosporine A delivery to the eye: a comprehensive review of academic and industrial efforts [J]. Eur J Pharm Biopharm, 2017, 117: 14-28.
[31]
TERRENI E, CHETONI P, TAMPUCCI S, et al. Assembling surfactants-mucoadhesive polymer nanomicelles(ASMP-nano) for ocular delivery of cyclosporine-A [J]. Pharmaceutics, 2020, 12(3): 253.
[32]
CHOLKAR K, GILGER B C, MITRA A K. Topical, aqueous, clear cyclosporine formulation design for anterior and posterior ocular delivery [J]. Transl Vis Sci Technol,2015, 4(3): 1.
[33]
PENG W Y, CHEN R X, DAI H, et al. Efficacy, safety, and tolerability of a novel cyclosporine, a formulation for dry eye disease: a multicenter phase Ⅱ clinical study [J]. Clin Ther, 2021, 43(3): 613-628.
[34]
DUAN Y W, CAI X Q, DU H L, et al. Novel in situ gel systems based on P123/TPGS mixed micelles and gellan gum for ophthalmic delivery of curcumin [J]. Colloids Surf B Biointerfaces, 2015, 128: 322-330.
[35]
WU Y J, YAO J, ZHOU J P, et al. Enhanced and sustained topical ocular delivery of cyclosporine A in thermosensitive hyaluronic acid-based in situ forming microgels [J]. Int J Nanomedicine, 2013, 8: 3587-3601.
[36]
TERRENI E, ZUCCHETTI E, TAMPUCCI S, et al. Combination of nanomicellar technology and in situ gelling polymer as ocular drug delivery system(ODDS) for cyclosporine-A [J]. Pharmaceutics, 2021, 13(2): 192.
[37]
ASHARA K C, PAUN J S, SONIWALA M M, et al. Microemulgel: an overwhelming approach to improve therapeutic action of drug moiety [J]. Saudi Pharm J, 2016,24(4): 452-457.
[38]
SHEN Y, LING X, JIANG W W, et al. Formulation and evaluation of cyclosporin A emulgel for ocular delivery[J]. Drug Deliv, 2015, 22(7): 911-917.
[39]
HASANNIA M, ALIABADI A, ABNOUS K, et al. Synthesis of block copolymers used in polymersome fabrication: application in drug delivery [J]. J Control Release, 2022, 341: 95-117.
[40]
ALSHAMSAN A, ABUL KALAM M, VAKILI M R, et al. Treatment of endotoxin-induced uveitis by topical application of cyclosporine a-loaded PolyGel™ in rabbit eyes [J]. Int J Pharm, 2019, 569: 118573.
[41]
PROSPERI-PORTA G, KEDZIOR S, MUIRHEAD B, et al. Phenylboronic-acid-based polymeric micelles for mucoadhesive anterior segment ocular drug delivery [J]. Biomacromolecules, 2016, 17(4): 1449-1457.
[42]
HUCKABY J T, LAI S K. PEGylation for enhancing nanoparticle diffusion in mucus [J]. Adv Drug Deliv Rev,2018, 124: 125-139.
[43]
POPOV A. Mucus-penetrating particles and the role of ocular mucus as a barrier to micro- and nanosuspensions[J]. J Ocul Pharmacol Ther, 2020, 36(6): 366-375.
[44]
YAN R, XU L, WANG Q H, et al. Cyclosporine A nanosuspensions for ophthalmic delivery: a comparative study between cationic nanoparticles and drug-core mucus penetrating nanoparticles [J]. Mol Pharm, 2021, 18(12):4290-4298.
[45]
DAULL P, LALLEMAND F, GARRIGUE J S. Benefits of cetalkonium chloride cationic oil-in-water nanoemulsions for topical ophthalmic drug delivery [J]. J Pharm Pharmacol, 2014, 66(4): 531-541.
[46]
DAULL P, FERAILLE L, BARABINO S, et al. Efficacy of a new topical cationic emulsion of cyclosporine A on dry eye clinical signs in an experimental mouse model of dry eye[J]. Exp Eye Res, 2016, 153: 159-164.
[47]
LANGEL Ü. Cell-penetrating peptides and transportan[J]. Pharmaceutics, 2021, 13(7): 987.
[48]
PESCINA S, OSTACOLO C, GOMEZ-MONTERREY I M, et al. Cell penetrating peptides in ocular drug delivery: state of the art [J]. J Control Release, 2018, 284: 84-102.
[49]
HYUN S, LI L, YOON K C, et al. An amphipathic cell penetrating peptide aids cell penetration of cyclosporin A and increases its therapeutic effect in an in vivo mouse model for dry eye disease [J]. Chem Commun (Camb), 2019,55(91): 13657-13660.
[50]
ZAMBOULIS A, NANAKI S, MICHAILIDOU G, et al. Chitosan and its derivatives for ocular delivery formulations:recent advances and developments [J]. Polymers (Basel),2020, 12(7): 1519.
[51]
BONFERONI M C, SANDRI G, DELLERA E, et al. Palmitoyl glycol chitosan micelles for corneal delivery of cyclosporine [J]. J Biomed Nanotechnol, 2016, 12(1): 231-240.
[52]
UCHEGBU I F, BREZNIKAR J, ZAFFALON A, et al. Polymeric micelles for the enhanced deposition of hydrophobic drugs into ocular tissues, without plasma exposure [J]. Pharmaceutics, 2021, 13(5): 744.
[53]
ALVAREZ-TRABADO J, LÓPEZ-GARCÍA A, MARTíN-PASTOR M, et al. Sorbitan ester nanoparticles(SENS) as a novel topical ocular drug delivery system: design, optimization, and in vitro/ex vivo evaluation [J]. Int J Pharm, 2018, 546(1/2): 20-30.
[54]
LIU Y, WANG Y N, YANG J L, et al. Cationized hyaluronic acid coated spanlastics for cyclosporine A ocular delivery:prolonged ocular retention, enhanced corneal permeation and improved tear production [J]. Int J Pharm, 2019, 565: 133-142.
[55]
MUN J, MOK J W, JEONG S, et al. Drug-eluting contact lens containing cyclosporine-loaded cholesterol-hyaluronate micelles for dry eye syndrome [J]. RSC Adv, 2019, 9(29):16578-16585.
[56]
UWAEZUOKE O, DU TOIT L C, KUMAR P, et al. Linoleic acid-based transferosomes for topical ocular delivery of cyclosporine A [J]. Pharmaceutics, 2022, 14(8): 1695.
[57]
GHEZZI M, FERRABOSCHI I, DELLEDONNE A, et al. Cyclosporine-loaded micelles for ocular delivery:investigating the penetration mechanisms [J]. J Control Release, 2022, 349: 744-755.
2023年第54卷第11期
19
3
0
引用本文
BibTeX
文章信息
doi: 10.16522/j.cnki.cjph.2023.11.005
  • 接收时间:2023-01-16
  • 首发时间:2026-11-19
  • 出版时间:2023-11-10
补充材料
相关文章
文章信息
作者
出版历史
  • 收稿日期:2023-01-16
基金
国家自然科学基金资助项目(81973251)
河北省自然科学基金资助项目(H2019206445)
河北省2021年度医学科学研究课题(20211108)
作者信息
    1.河北医科大学药学院,河北 石家庄 050017
    2.河北化工医药职业技术学院,河北 石家庄 050030

通讯作者:

李素霞(1981—),女,硕士,讲师,从事新型纳米药物递送系统的研究。E-mail:
向柏(1978—),男,博士,教授,从事新型纳米载体在疾病诊疗中的应用研究。E-mail:
参考文献
分享链接
https://castjournals.cast.org.cn/joweb/zgyygy/CN/10.16522/j.cnki.cjph.2023.11.005
分享至
全文二维码

扫描看全文

引用本文
BibTeX
本文的引用情况
2种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏